COSM (Cosmos Health) Total Current Assets : $36.24 Mil (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Cosmos Health Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Cosmos Health's total current assets for the quarter that ended in Sep. 2024 was $36.24 Mil.

Cosmos Health Total Current Assets Historical Data

The historical data trend for Cosmos Health's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmos Health Total Current Assets Chart

Cosmos Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

21.18

40.77

39.83

56.37

36.61

Cosmos Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Current Assets	Get a 7-Day Free Trial															46.49	36.61	34.29	33.42	36.24

Cosmos Health Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Cosmos Health's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	3.853	+	21.713	+	4.789	+	6.253
	=	36.61

Cosmos Health's Total Current Assets for the quarter that ended in Sep. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	3.338	+	19.708	+	4.885	+	8.308
	=	36.24

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Cosmos Health (NAS:COSM) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Cosmos Health's Liquidation Value for the quarter that ended in Sep. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3.338	-	29.543	+	0.75 * 17.484	+	0.5 * 4.885
=	-10.65

Cosmos Health Total Current Assets Related Terms

Thank you for viewing the detailed overview of Cosmos Health's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmos Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cosmos Health Inc (NAS:COSM) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

V67A:Germany

Address

5 Agiou Georgiou Street, Thessaloniki, Thessaloniki, GRC, 55438

Website

https://www.cosmoshealthinc.com

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

Executives

Grigorios Siokas	10 percent owner	5 AG. GEORGIOU STR., PILEA, THESSALONIKI J3 TK57001
Georgios Terzis	officer: Chief Financial Officer	2 MELITOS STR., NEA SMIRNI, ATTICA J3 17121
Suhel Bhutawala	director	141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Nikolaos Bardakis	officer: Chief Operating Officer	141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Manfred Ziegler	director	141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Anastasios Aslidis	director	11 CANTERBURY LANE, WATCHUNG NJ 07069
Pavlos Ignatiades	officer: Chief Operating Officer	KALAPATHAKI 5, PANORAMA, THESSALONIKI J3 55236
Peter Goldstein	director	151 NORTH NOB HILL ROAD SUITE 321, FORT LAUDERDALE FL 33324
John James Hoidas	director	9301 S. HARLEM AVENUE, OAK LAWN, CHICAGO IL 60453
Dimitrios Goulielmos	director, 10 percent owner, officer: CEO	141 WEST JACKSON BLVD, SUITE 4236, CHICAGO IL 60604
Panagiotis Tolis	director, officer: Secretary	PERICLEOUS 50 STREET, ATHENS J3 15232
Panagiotis Drakopoulos	director, 10 percent owner, officer: CEO	200 SOUTH WACKER DRIVE, SUITE 300, CHICAGO IL 60606
Vasileios Mavrogiannis	director, 10 percent owner, officer: CFO	TERTSETI 23 STREET, KESARIANI J3 16122